Terms: = Prostate cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Diagnosis
13 results:
1. Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in prostate cancer.
Eiro N; Medina A; Gonzalez LO; Fraile M; Palacios A; Escaf S; Fernández-Gómez JM; Vizoso FJ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108185
[TBL] [Abstract] [Full Text] [Related]
2. Association of the Omega-3 Index with Incident prostate cancer with Updated Meta-Analysis: The Cooper Center Longitudinal Study.
Farrell SW; DeFina LF; Tintle NL; Leonard D; Cooper KH; Barlow CE; Haskell WL; Pavlovic A; Harris WS
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33530576
[TBL] [Abstract] [Full Text] [Related]
3. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic cancer Early Detection.
Fahrmann JF; Schmidt CM; Mao X; Irajizad E; Loftus M; Zhang J; Patel N; Vykoukal J; Dennison JB; Long JP; Do KA; Zhang J; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger J; Yip-Schneider MT; Maitra A; Wolpin BM; Hanash S
Gastroenterology; 2021 Mar; 160(4):1373-1383.e6. PubMed ID: 33333055
[TBL] [Abstract] [Full Text] [Related]
4. prostate cancer survivors with symptoms of radiation cystitis have elevated fibrotic and vascular proteins in urine.
Zwaans BMM; Nicolai HE; Chancellor MB; Lamb LE
PLoS One; 2020; 15(10):e0241388. PubMed ID: 33119677
[TBL] [Abstract] [Full Text] [Related]
5. Comparative analysis of the expression of metalloproteases (MMP-2, MMP-9, MMP-11 and MMP-13) and the tissue inhibitor of metalloprotease 3 (timp-3) between previous negative biopsies and radical prostatectomies.
Medina-González A; Eiró-Díaz N; Fernández-Gómez JM; Ovidio-González L; Jalón-Monzón A; Casas-Nebra J; Escaf-Barmadah S
Actas Urol Esp (Engl Ed); 2020 Mar; 44(2):78-85. PubMed ID: 31899007
[TBL] [Abstract] [Full Text] [Related]
6. Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival.
Xie W; Stopsack KH; Drouin SJ; Fu H; Pomerantz MM; Mucci LA; Lee GM; Kantoff PW
Prostate; 2019 Jan; 79(1):73-80. PubMed ID: 30141208
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-124a inhibits cell proliferation and migration in liver cancer by regulating interleukin-11.
Yu L; Wang S; Lin X; Lu Y; Gu P
Mol Med Rep; 2018 Mar; 17(3):3972-3978. PubMed ID: 29286137
[TBL] [Abstract] [Full Text] [Related]
8. Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance.
Moreel X; Allaire J; Léger C; Caron A; Labonté MÈ; Lamarche B; Julien P; Desmeules P; Têtu B; Fradet V
Cancer Prev Res (Phila); 2014 Jul; 7(7):766-76. PubMed ID: 24824038
[TBL] [Abstract] [Full Text] [Related]
9. Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients.
Oh WK; Vargas R; Jacobus S; Leitzel K; Regan MM; Hamer P; Pierce K; Brown-Shimer S; Carney W; Ali SM; Kantoff PW; Lipton A
Cancer; 2011 Feb; 117(3):517-25. PubMed ID: 20862742
[TBL] [Abstract] [Full Text] [Related]
10. Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and prostate cancer.
Escaff S; Fernández JM; González LO; Suárez A; González-Reyes S; González JM; Vizoso FJ
J Cancer Res Clin Oncol; 2011 Mar; 137(3):551-5. PubMed ID: 20508949
[TBL] [Abstract] [Full Text] [Related]
11. Investigating the biomarker potential of glycoproteins using comparative glycoprofiling - application to tissue inhibitor of metalloproteinases-1.
Thaysen-Andersen M; Thøgersen IB; Lademann U; Offenberg H; Giessing AM; Enghild JJ; Nielsen HJ; Brünner N; Højrup P
Biochim Biophys Acta; 2008 Mar; 1784(3):455-63. PubMed ID: 18206988
[TBL] [Abstract] [Full Text] [Related]
12. Coordinated peak expression of MMP-26 and timp-4 in preinvasive human prostate tumor.
Lee S; Desai KK; Iczkowski KA; Newcomer RG; Wu KJ; Zhao YG; Tan WW; Roycik MD; Sang QX
Cell Res; 2006 Sep; 16(9):750-8. PubMed ID: 16940965
[TBL] [Abstract] [Full Text] [Related]
13. Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer.
Morgia G; Falsaperla M; Malaponte G; Madonia M; Indelicato M; Travali S; Mazzarino MC
Urol Res; 2005 Feb; 33(1):44-50. PubMed ID: 15517230
[TBL] [Abstract] [Full Text] [Related]
